Uikeaft Wart and Corn Remover

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the removal of corns, calluses, plantar warts, flat warts, and common warts that are less than 5 mm in size.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned thoroughly with warm water prior to application. Following this, the inner plug must be removed from the bottle. The brush should be installed into the bottle cap by pressing it tightly, ensuring that the cap is securely tightened onto the bottle.

The solution is to be applied directly to the wart, corn, or callus. For larger areas, it is recommended to use the solution consistently over time to achieve optimal results.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with a known allergy to any of the ingredients in this product should not use it due to the risk of allergic reactions. Additionally, the product is contraindicated in pregnant or breastfeeding individuals unless specifically directed by a healthcare professional, as the safety in these populations has not been established.

The product should not be applied to damaged skin, including areas with cuts, abrasions, eczema, or sunburn, due to the potential for increased irritation or adverse effects.

Warnings and Precautions

For external use only. This product is contraindicated for application on damaged skin, which includes areas with cuts, abrasions, eczema, or sunburn. It is imperative that individuals do not use this product if they have a known allergy to any of its ingredients.

Healthcare professionals should advise patients against using this product during pregnancy or while breastfeeding unless specifically directed by a physician.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are instructed to discontinue use and consult their healthcare provider if they become pregnant or are planning to become pregnant while using this product. Additionally, they should seek medical advice if they experience any irritation or redness, or if their condition worsens or fails to improve after regular use.

Side Effects

For external use only. Patients are advised to discontinue use and consult a healthcare professional if they become pregnant or are planning to become pregnant while using this product. Additionally, if irritation or redness occurs, or if the condition worsens or does not improve after regular use, patients should stop using the product and seek medical advice.

It is important for patients to be aware of these warnings and to monitor their condition closely while using the product.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Uikeaft Wart and Corn Remover (wart and corn remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product only under adult supervision to ensure safety and proper administration. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product unless directed by a healthcare professional. It is advised that patients discontinue use immediately if they become pregnant or are planning to become pregnant while using this product. Women of childbearing potential are encouraged to consult with their healthcare provider if they become pregnant or are planning to become pregnant during treatment. The potential risks and effects on fetal outcomes have not been established, and caution is warranted in this population.

Lactation

Lactating mothers are advised against using this medication while breastfeeding unless specifically directed by a healthcare professional. There is no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication in lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, the following management procedures are recommended:

1. Assessment: Conduct a thorough assessment of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as necessary, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Consultation: Engage with a poison control center or toxicology expert for guidance on specific interventions and antidotes that may be appropriate based on the substance involved.

4. Documentation: Document all findings, interventions, and the patient's response to treatment meticulously.

Healthcare professionals should remain vigilant and prepared to implement these measures in the event of an overdose, despite the lack of specific information provided.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or breastfeeding individuals unless directed by a healthcare professional. It is advised to discontinue use if pregnancy occurs or if there are plans to become pregnant while using this product. Consultation with a healthcare provider is recommended in such circumstances.

No non-teratogenic effects have been explicitly stated in the available data. Additionally, there are no specific findings related to animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to damaged skin, including areas with cuts, abrasions, eczema, or sunburn.

Patients should be cautioned to avoid using the product if they have a known allergy to any of its ingredients. Additionally, healthcare providers should discuss the use of this product during pregnancy or breastfeeding, emphasizing that it should only be used if directed by a doctor. Patients who become pregnant or are planning to become pregnant while using the product should also be advised to consult their healthcare provider.

Patients should be informed to monitor for any signs of irritation or redness and to discontinue use if these symptoms occur. They should also be instructed to seek medical advice if their condition worsens or does not improve after regular use.

It is essential to advise patients to avoid contact with their eyes. In the event of contact, they should flush their eyes thoroughly with water. Patients should be reminded not to swallow the product and that children should only use it under adult supervision.

Healthcare providers should emphasize the importance of avoiding prolonged exposure to air while using the product, as it can easily volatilize and crystallize. Patients should be instructed to tighten the cap after each use and to refrain from using the product if the seal is broken or missing.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers. It should be stored at a temperature range of 20° to 25°C (68° to 77°F) to maintain its integrity. It is essential to keep the container tightly closed to protect the contents from contamination and ensure optimal stability.

Additional Clinical Information

The product is administered topically. It is important for clinicians to counsel patients, particularly regarding the use of this product in children, who should only use it under adult supervision. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Uikeaft Wart and Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)